Literature DB >> 30351123

Prediction of Misfolding-Specific Epitopes in SOD1 Using Collective Coordinates.

Xubiao Peng1,2, Neil R Cashman3, Steven S Plotkin4.   

Abstract

We introduce a global, collective coordinate bias into molecular dynamics simulations that partially unfolds a protein, in order to predict misfolding-specific epitopes based on the regions that locally unfold. Several metrics are used to measure local disorder, including solvent exposed surface area (SASA), native contacts ( Q), and root mean squared fluctuations (RMSF). The method is applied to Cu, Zn superoxide dismutase (SOD1). For this protein, the processes of monomerization, metal loss, and conformational unfolding due to microenvironmental stresses are all separately taken into account. Several misfolding-specific epitopes are predicted, and consensus epitopes are calculated. These predicted epitopes are consistent with the "lower-resolution" peptide sequences used to raise disease-specific antibodies, but the epitopes derived from collective coordinates contain shorter, more refined sequences for the key residues constituting the epitope.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30351123     DOI: 10.1021/acs.jpcb.8b07680

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  9 in total

1.  TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.

Authors:  Sabrina Semmler; Myriam Gagné; Pranav Garg; Sarah R Pickles; Charlotte Baudouin; Emeline Hamon-Keromen; Laurie Destroismaisons; Yousra Khalfallah; Mathilde Chaineau; Elise Caron; Andrew N Bayne; Jean-François Trempe; Neil R Cashman; Alexandra T Star; Arsalan S Haqqani; Thomas M Durcan; Elizabeth M Meiering; Janice Robertson; Nathalie Grandvaux; Steven S Plotkin; Heidi M McBride; Christine Vande Velde
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

2.  Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide "Glycindel" Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson's Disease.

Authors:  Shawn C C Hsueh; Adekunle Aina; Andrei Yu Roman; Neil R Cashman; Xubiao Peng; Steven S Plotkin
Journal:  ACS Chem Neurosci       Date:  2022-07-15       Impact factor: 5.780

3.  A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer's Disease.

Authors:  Ebrima Gibbs; Judith M Silverman; Beibei Zhao; Xubiao Peng; Jing Wang; Cheryl L Wellington; Ian R Mackenzie; Steven S Plotkin; Johanne M Kaplan; Neil R Cashman
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

Review 4.  Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases.

Authors:  Luke McAlary; Steven S Plotkin; Neil R Cashman
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

5.  Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis.

Authors:  Luke McAlary; Steven S Plotkin; Justin J Yerbury; Neil R Cashman
Journal:  Front Mol Neurosci       Date:  2019-11-01       Impact factor: 5.639

6.  First Principles Calculation of Protein-Protein Dimer Affinities of ALS-Associated SOD1 Mutants.

Authors:  Shawn C C Hsueh; Mark Nijland; Xubiao Peng; Benjamin Hilton; Steven S Plotkin
Journal:  Front Mol Biosci       Date:  2022-03-24

7.  Free energy calculations of ALS-causing SOD1 mutants reveal common perturbations to stability and dynamics along the maturation pathway.

Authors:  Nicholas G M Wells; Grant A Tillinghast; Alison L O'Neil; Colin A Smith
Journal:  Protein Sci       Date:  2021-06-22       Impact factor: 6.993

Review 8.  Passive immunotherapies targeting Aβ and tau in Alzheimer's disease.

Authors:  Steven S Plotkin; Neil R Cashman
Journal:  Neurobiol Dis       Date:  2020-07-16       Impact factor: 7.046

9.  Computational Insights into the Unfolding of a Destabilized Superoxide Dismutase 1 Mutant.

Authors:  Stepan Timr; Fabio Sterpone
Journal:  Biology (Basel)       Date:  2021-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.